Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.9 USD | +0.71% | +2.12% | -35.44% |
24/06 | JPMorgan Cuts Price Target on Cytokinetics to $65 From $77, Maintains Overweight Rating | MT |
17/06 | Cytokinetics Insider Sold Shares Worth $262,750, According to a Recent SEC Filing | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.44% | 626.34Cr | |
+16.73% | 12TCr | |
+21.13% | 11TCr | |
+18.05% | 2.59TCr | |
-17.94% | 2.09TCr | |
-16.24% | 1.65TCr | |
-11.76% | 1.68TCr | |
-44.45% | 1.56TCr | |
+69.92% | 1.55TCr | |
+1.41% | 1.34TCr |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics Insider Sold Shares Worth $413,106, According to a Recent SEC Filing